Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Perampanel Monotherapy in Epilepsy Patients with Focal and Generalized Seizures

Trial Profile

Perampanel Monotherapy in Epilepsy Patients with Focal and Generalized Seizures

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Jun 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Perampanel (Primary)
  • Indications Generalised seizures; Seizures
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 22 Apr 2021 Results assessing real-world effectiveness, safety and tolerability of perampanel (PER) when used as monotherapy in everyday clinical practice presented at the 73rd Annual Meeting of the American Academy of Neurology
    • 25 Jan 2021 New trial record
    • 08 Dec 2020 Results (n=102) presented at the 74th Annual Meeting of the American Epilepsy Society
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top